Reduced isoalpha acid based protein kinase modulation cancer treatment

Details for Australian Patent Application No. 2007261399 (hide)

Owner Metaproteomics, LLC

Inventors Konda, Veera; Desai, Anu; Tripp, Matthew L.; Babish, John G.; Bland, Jeffrey; Hall, Amy Jennae; Pacioretty, Linda

Agent Davies Collison Cave

Pub. Number AU-A-2007261399

PCT Pub. Number WO2007/149480

Priority 60/815,064 20.06.06 US

Filing date 20 June 2007

Wipo publication date 27 December 2007

International Classifications

A61K 36/00 (2006.01) Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines

A61K 35/00 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 36/18 (2006.01) Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines - Magnoliophyta (angiosperms)

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

Event Publications

5 February 2009 PCT application entered the National Phase

  PCT publication WO2007/149480 Priority application(s): WO2007/149480

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007261400-Tetrahydro-isoalpha acid based protein kinase modulation cancer treatment

2007261398-Pyrazine derivatives and uses thereof in renal monitoring